Drug: thalidomide Quarter: 2016Q3
Total Drug/Injury Combinations: 254 Number of Pages: 13
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| THALIDOMIDE | Vision blurred | 1 | view events |
| THALIDOMIDE | Weight decreased | 1 | view events |
| THALIDOMIDE | White blood cell count decreased | 1 | view events |
| THALIDOMIDE (Manufacturer Unknown) | Leukaemia | 1 | view events |
| Thalidomide Celgene | Acute myeloid leukaemia | 1 | view events |
| Thalidomide Celgene | Adenocarcinoma of colon | 1 | view events |
| Thalidomide Celgene | Congestive cardiomyopathy | 1 | view events |
| Thalidomide Celgene | Ejection fraction decreased | 1 | view events |
| Thalidomide Celgene | Fracture | 1 | view events |
| Thalidomide Celgene | Leukaemia | 1 | view events |
| THALIDOMIDE CELGENE | Plasma cell myeloma | 1 | view events |
| Thalidomide Celgene | Pregnancy of partner | 1 | view events |
| Thalidomide Celgene | Small intestinal obstruction | 1 | view events |
| Thalidomide Celgene | Visual impairment | 1 | view events |
Total Drug/Injury Combinations: 254 Number of Pages: 13
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)